– Blooomberg
Oncolytics Biotech Announces Preclinical Data Demonstrating The Synergistic Immunotherapeutic Effects Of Pelareorep Combined With Radiotherapy
Oncolytics Biotech® Inc. (NASDAQ:ONCY) (TSX:ONC) today announced preclinical data demonstrating the synergistic immunotherapeutic effects of pelareorep combined with radiotherapy in a murine cancer model. The data